Trial Profile
A PET [positron emission tomography] study examining the dopaminergic activity of armodafinil in adults.
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs Armodafinil (Primary) ; Methylphenidate
- Indications Bipolar depression
- Focus Pharmacokinetics
- 09 Jun 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 30 Sep 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 30 Jan 2008 New trial record.